prikaz prve stranice dokumenta Global impact of the COVID-19 pandemic on subarachnoid haemorrhage hospitalisations, aneurysm treatment and in-hospital mortality: 1-year follow-up
  Download
PDF 1.74 MB
Scientific paper - Original scientific paper
Global impact of the COVID-19 pandemic on subarachnoid haemorrhage hospitalisations, aneurysm treatment and in-hospital mortality: 1-year follow-up
Journal of Neurology, Neurosurgery & Psychiatry, 93 (2022), 10; 1028-1038. https://doi.org/10.1136/jnnp-2022-329200
(SVIN COVID-19 Global SAH Registry) Nguyen, Thanh N.; Roje Bedekovic, Marina; Budincevic, Hrvoje

Cite this document

Nguyen, T. N., Roje Bedekovic, M. & Budincevic, H. (2022). Global impact of the COVID-19 pandemic on subarachnoid haemorrhage hospitalisations, aneurysm treatment and in-hospital mortality: 1-year follow-up. Journal of Neurology, Neurosurgery & Psychiatry, 93. (10), 1028-1038. doi: 10.1136/jnnp-2022-329200

Nguyen, Thanh N., et al. "Global impact of the COVID-19 pandemic on subarachnoid haemorrhage hospitalisations, aneurysm treatment and in-hospital mortality: 1-year follow-up." Journal of Neurology, Neurosurgery & Psychiatry, vol. 93, no. 10, 2022, pp. 1028-1038. https://doi.org/10.1136/jnnp-2022-329200

Nguyen, Thanh N., Marina Roje Bedekovic and Hrvoje Budincevic. "Global impact of the COVID-19 pandemic on subarachnoid haemorrhage hospitalisations, aneurysm treatment and in-hospital mortality: 1-year follow-up." Journal of Neurology, Neurosurgery & Psychiatry 93, no. 10 (2022): 1028-1038. https://doi.org/10.1136/jnnp-2022-329200

Nguyen, T. N., Roje Bedekovic, M. and Budincevic, H. (2022) 'Global impact of the COVID-19 pandemic on subarachnoid haemorrhage hospitalisations, aneurysm treatment and in-hospital mortality: 1-year follow-up', Journal of Neurology, Neurosurgery & Psychiatry, 93(10), pp. 1028-1038. doi: 10.1136/jnnp-2022-329200

Nguyen TN, Roje Bedekovic M, Budincevic H. Global impact of the COVID-19 pandemic on subarachnoid haemorrhage hospitalisations, aneurysm treatment and in-hospital mortality: 1-year follow-up. Journal of Neurology, Neurosurgery & Psychiatry [Internet]. 2022 October [cited 2024 November 22];93(10):1028-1038. doi: 10.1136/jnnp-2022-329200

T. N. Nguyen, M. Roje Bedekovic and H. Budincevic, "Global impact of the COVID-19 pandemic on subarachnoid haemorrhage hospitalisations, aneurysm treatment and in-hospital mortality: 1-year follow-up", Journal of Neurology, Neurosurgery & Psychiatry, vol. 93, no. 10, pp. 1028-1038, October 2022. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:220:834541. [Accessed: 22 November 2024]

Please login to the repository to save this object to your list.
Metadata
Title (english)Global impact of the COVID-19 pandemic on subarachnoid haemorrhage hospitalisations, aneurysm treatment and in-hospital mortality: 1-year follow-up
AuthorThanh N. Nguyen
AuthorMarina Roje Bedekovic
AuthorHrvoje Budincevic
CollaborationSVIN COVID-19 Global SAH Registry
Author's institution(Sestre milosrdnice University Hospital Center)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Neurology
Abstract (english)
Background: Prior studies indicated a decrease in the incidences of aneurysmal subarachnoid haemorrhage (aSAH) during the early stages of the COVID-19 pandemic. We evaluated differences in the incidence, severity of aSAH presentation, and ruptured aneurysm treatment modality during the first year of the COVID-19 pandemic compared with the preceding year. Methods: We conducted a cross-sectional study including 49 countries and 187 centres. We recorded volumes for COVID-19 hospitalisations, aSAH hospitalisations, Hunt-Hess grade, coiling, clipping and aSAH in-hospital mortality. Diagnoses were identified by International Classification of Diseases, 10th Revision, codes or stroke databases from January 2019 to May 2021. Results: Over the study period, there were 16 247 aSAH admissions, 344 491 COVID-19 admissions, 8300 ruptured aneurysm coiling and 4240 ruptured aneurysm clipping procedures. Declines were observed in aSAH admissions (−6.4% (95% CI −7.0% to −5.8%), p=0.0001) during the first year of the pandemic compared with the prior year, most pronounced in high-volume SAH and high-volume COVID-19 hospitals. There was a trend towards a decline in mild and moderate presentations of subarachnoid haemorrhage (SAH) (mild: −5% (95% CI −5.9% to –4.3%), p=0.06; moderate: −8.3% (95% CI −10.2% to –6.7%), p=0.06) but no difference in higher SAH severity. The ruptured aneurysm clipping rate remained unchanged (30.7% vs 31.2%, p=0.58), whereas ruptured aneurysm coiling increased (53.97% vs 56.5%, p=0.009). There was no difference in aSAH in-hospital mortality rate (19.1% vs 20.1%, p=0.12). Conclusion: During the first year of the pandemic, there was a decrease in aSAH admissions volume, driven by a decrease in mild to moderate presentation of aSAH. There was an increase in the ruptured aneurysm coiling rate but neither change in the ruptured aneurysm clipping rate nor change in aSAH in-hospital mortality.
Languageenglish
Publication typeScientific paper - Original scientific paper
Publication statusPublished
Peer reviewPeer review
Publication versionPublished version
Journal titleJournal of Neurology, Neurosurgery & Psychiatry
Numberingvol. 93, no. 10, pp. 1028-1038
p-ISSN0022-3050
e-ISSN1468-330X
DOIhttps://doi.org/10.1136/jnnp-2022-329200
URN:NBNurn:nbn:hr:220:834541
Publication2022-10
Document URLhttps://jnnp.bmj.com/lookup/doi/10.1136/jnnp-2022-329200
Type of resourceText
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2024-08-22 10:59:08